Microbiological and Epidemiological Aspects of Endocarditis Caused by Rothia spp.: A Systematic Review

A. Norberg, Paulo Roberto Blanco Moreira Norberg, Fernanda Castro Manhães, B. M. Mangiavacchi, Renato Mataveli Ferreira Filho, Juliana Toledo Campos Arêas, Sabrina Jorge Rodrigues, Davyson Gerhardt de Souza, Igor Villas Silva Gazeta Veríssimo, Kelen Salaroli Viana, Julio Cesar dos Santos Boechat
{"title":"Microbiological and Epidemiological Aspects of Endocarditis Caused by Rothia spp.: A Systematic Review","authors":"A. Norberg, Paulo Roberto Blanco Moreira Norberg, Fernanda Castro Manhães, B. M. Mangiavacchi, Renato Mataveli Ferreira Filho, Juliana Toledo Campos Arêas, Sabrina Jorge Rodrigues, Davyson Gerhardt de Souza, Igor Villas Silva Gazeta Veríssimo, Kelen Salaroli Viana, Julio Cesar dos Santos Boechat","doi":"10.9734/jammr/2023/v35i245328","DOIUrl":null,"url":null,"abstract":"Background and Aim: Rothia, a genus comprising pleomorphic Gram-positive bacteria found in the human oral, intestinal, and skin microbiota, is recognized as an opportunistic pathogen. Case reports of Rothia spp. endocarditis in the scientific literature are scarce, with limited knowledge of relevant data on Rothia endocarditis and clinical aspects of its treatment. The objective of this literature review is to compile clinical aspects of endocarditis caused by Rothia species, analyzing results and clinical practices to elucidate the most important risk factors, comorbidities, prognostic factors, and appropriate antibiotic treatment options. \nMethods: Employing the PRISMA model, a systematic review was conducted utilizing PubMed, SciELO, and Google Scholar databases, encompassing articles published from 1978 to November 2023. Pertinent aspects were systematically recorded and summarized for subsequent analysis. \nResults: Rothia dentocariosa (48.69%), Rothia mucilaginosa (22.37%), Rothia aeria (14.47%), and Rothia kristinae (14.47%) were recognized as the agents of endocarditis cases. Patients exhibited an average age of 48.5 years, with a notable male preponderance (71.6%). Clinical manifestations of Rothia spp. endocarditis presented similar features compared to other Gram-positive bacterial endocarditis cases. The mortality rate was notably lower than observed in other infectious endocarditis instances (11.84%). Predominant risk factors included preexisting cardiovascular diseases (50%), followed by odontological procedures, caries, and precarious oral hygiene (17.1%), immunocompromised status (14.47%), injectable illicit drug use (11.84%), and diabetes (9.21%). Embolic events were documented in 35.53% of patients, predominantly in Central Nervous System (28.95%). Mycotic aneurysms were identified in 6.58% of cases. Resistance to antibiotics was identified in only 13.16% of strains causing endocarditis, although certain strains displayed characteristics indicative of multidrug resistance. \nConclusion: Despite its rarity, Rothia spp. endocarditis exhibits clinical parallels with endocarditis caused by other Gram-positive bacteria, but with a comparatively lower mortality rate. Challenges in identifying Rothia spp. species based on cultural and microscopic characteristics, associated to early resolution in antibiotic therapy, seems to contribute to the underreporting of endocarditis caused by these bacteria.","PeriodicalId":14869,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"26 23","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advances in Medicine and Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jammr/2023/v35i245328","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Aim: Rothia, a genus comprising pleomorphic Gram-positive bacteria found in the human oral, intestinal, and skin microbiota, is recognized as an opportunistic pathogen. Case reports of Rothia spp. endocarditis in the scientific literature are scarce, with limited knowledge of relevant data on Rothia endocarditis and clinical aspects of its treatment. The objective of this literature review is to compile clinical aspects of endocarditis caused by Rothia species, analyzing results and clinical practices to elucidate the most important risk factors, comorbidities, prognostic factors, and appropriate antibiotic treatment options. Methods: Employing the PRISMA model, a systematic review was conducted utilizing PubMed, SciELO, and Google Scholar databases, encompassing articles published from 1978 to November 2023. Pertinent aspects were systematically recorded and summarized for subsequent analysis. Results: Rothia dentocariosa (48.69%), Rothia mucilaginosa (22.37%), Rothia aeria (14.47%), and Rothia kristinae (14.47%) were recognized as the agents of endocarditis cases. Patients exhibited an average age of 48.5 years, with a notable male preponderance (71.6%). Clinical manifestations of Rothia spp. endocarditis presented similar features compared to other Gram-positive bacterial endocarditis cases. The mortality rate was notably lower than observed in other infectious endocarditis instances (11.84%). Predominant risk factors included preexisting cardiovascular diseases (50%), followed by odontological procedures, caries, and precarious oral hygiene (17.1%), immunocompromised status (14.47%), injectable illicit drug use (11.84%), and diabetes (9.21%). Embolic events were documented in 35.53% of patients, predominantly in Central Nervous System (28.95%). Mycotic aneurysms were identified in 6.58% of cases. Resistance to antibiotics was identified in only 13.16% of strains causing endocarditis, although certain strains displayed characteristics indicative of multidrug resistance. Conclusion: Despite its rarity, Rothia spp. endocarditis exhibits clinical parallels with endocarditis caused by other Gram-positive bacteria, but with a comparatively lower mortality rate. Challenges in identifying Rothia spp. species based on cultural and microscopic characteristics, associated to early resolution in antibiotic therapy, seems to contribute to the underreporting of endocarditis caused by these bacteria.
罗氏菌引起的心内膜炎的微生物学和流行病学方面:系统综述
背景和目的:Rothia 属由多形性革兰氏阳性菌组成,存在于人类口腔、肠道和皮肤微生物群中,是公认的机会性病原体。科学文献中有关罗氏菌属心内膜炎的病例报告很少,对罗氏菌属心内膜炎的相关数据及其临床治疗方面的知识也很有限。本文献综述旨在汇编罗氏菌引起的心内膜炎的临床方面,分析结果和临床实践,以阐明最重要的风险因素、合并症、预后因素和适当的抗生素治疗方案。方法:采用 PRISMA 模型,利用 PubMed、SciELO 和 Google Scholar 数据库进行了系统性回顾,涵盖了 1978 年至 2023 年 11 月期间发表的文章。系统地记录并总结了相关内容,以便进行后续分析。结果确认引发心内膜炎病例的病原体为牙科罗希菌(48.69%)、粘液罗希菌(22.37%)、绿脓杆菌(14.47%)和克里斯汀菌(14.47%)。患者的平均年龄为 48.5 岁,男性明显占多数(71.6%)。罗氏菌心内膜炎的临床表现与其他革兰氏阳性细菌性心内膜炎病例相似。死亡率明显低于其他感染性心内膜炎病例(11.84%)。主要的风险因素包括已有的心血管疾病(50%),其次是牙科手术、龋齿和口腔卫生不良(17.1%)、免疫力低下(14.47%)、注射非法药物(11.84%)和糖尿病(9.21%)。据记录,35.53%的患者发生了栓塞事件,主要发生在中枢神经系统(28.95%)。6.58%的病例发现了霉菌性动脉瘤。在引起心内膜炎的菌株中,仅有 13.16% 的菌株对抗生素产生了耐药性,尽管某些菌株显示出了耐多药的特征。结论尽管罕见,但罗氏菌心内膜炎的临床表现与其他革兰氏阳性细菌引起的心内膜炎相似,但死亡率相对较低。根据培养和显微镜特征鉴别罗氏菌属物种的挑战与抗生素治疗的早期解决有关,这似乎是导致这些细菌引起的心内膜炎报告不足的原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信